Cancer and Eye Drugs Lift Genentech's Net.
In: Wall Street Journal - Eastern Edition, Jg. 250 (2007-07-12), Heft 9, S. A11
Zeitungsartikel
Zugriff:
The article reports on the financial performance of pharmaceutical firm Genentech Inc. Its profit for the second quarter of 2007 increased by 41 percent, largely due to the success of its cancer drug Avastin and eye-disease drug Lucentis. Sales of Avastin and Lucentis reached $564 million and $209 million, respectively.
Titel: |
Cancer and Eye Drugs Lift Genentech's Net.
|
---|---|
Autor/in / Beteiligte Person: | Loftus, Peter ; Vuocolo, Jonathan ; Lam, Judy |
Zeitschrift: | Wall Street Journal - Eastern Edition, Jg. 250 (2007-07-12), Heft 9, S. A11 |
Veröffentlichung: | 2007 |
Medientyp: | Zeitungsartikel |
ISSN: | 0099-9660 (print) |
Schlagwort: |
|
Sonstiges: |
|